Doctor profile · Federal record
Dr. Paul Brown, MD
Gastroenterology Physician · Louisville, KY
- NPI 1659355774
- MIPS 100.0 / 100 · 2023
- 21 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1169 Eastern Pkwy, G58
Louisville, KY 40217
(502) 452-9567
fax (502) 473-0586 - Mailing address
-
2020 Exeter RD
Germantown, TN 381383945
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- August 18, 2022
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Kentucky #24669
- Medicaid
- KY #64246697
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659355774. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,863
Distinct HCPCS
10
Medicare allowed
$226,059
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 6,300 | 12 | $22 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,110 | 13 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 157 | 130 | $118 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 75 | 75 | $153 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 43 | 42 | $123 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | 39 | $121 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 29 | 18 | $56 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 25 | 15 | $112 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 25 | 25 | $81 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 23 | 13 | $25 |
In context: peer comparison
Among 26 peers in Louisville Gastroenterology Physician, average services per provider: 84. This provider delivers 94× the peer median.Open Payments
Industry payments received
All-time total
$2,731
Transactions
135
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 31 | $538.44 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 23 | $369.78 | |
| Janssen Biotech, INC. | 18 | $242.42 | |
| Takeda Pharmaceuticals U.S.A., INC. | 13 | $214.31 | |
| Ardelyx, INC. | 8 | $145.27 | |
| Pfizer INC. | 8 | $134.99 | |
| Regeneron Healthcare Solutions, INC. | 5 | $129.06 | |
| Merck Sharp & Dohme LLC | 5 | $106.02 | |
| Qol Medical, LLC | 3 | $85.95 | |
| Aimmune Therapeutics, INC. | 3 | $80.51 | |
| Genzyme Corporation | 4 | $80.24 | |
| Phathom Pharmaceuticals, INC. | 5 | $74.65 | |
| Celgene Corporation | 3 | $58.78 | |
| Albireo Pharma, INC. | 3 | $55.45 | |
| Novo Nordisk INC | 3 | $53.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,069
Patients
575
Total drug cost
$189,776
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 778 | 208 | $10,209 |
| Omeprazole | Generic | 325 | 82 | $4,873 |
| Dicyclomine Hcl | Generic | 247 | 89 | $5,010 |
| Esomeprazole Magnesium | Generic | 151 | 47 | $9,957 |
| Linzess (Linaclotide) | Brand | 105 | 28 | $80,226 |
| Famotidine | Generic | 95 | 25 | $1,804 |
| Lansoprazole | Generic | 60 | 15 | $1,737 |
| Mesalamine ER (Mesalamine) | Brand | 46 | 0 | $15,409 |
| Mesalamine Dr (Mesalamine) | Brand | 42 | 0 | $19,576 |
| Metoclopramide Hcl | Generic | 42 | 13 | $552 |
Frequently asked questions
What is Dr. Paul Brown's medical specialty?
Dr. Paul Brown practices Gastroenterology Physician in Louisville, KY.
Where does Dr. Paul Brown practice?
Dr. Paul Brown practices at 1169 Eastern Pkwy, Louisville, KY 40217. Office phone: 5024529567.
What is Dr. Paul Brown's NPI?
Dr. Paul Brown's National Provider Identifier (NPI) is 1659355774, issued by NPPES.
What procedures does Dr. Paul Brown commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.